{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:12:58Z","timestamp":1791231178793,"version":"4.1.0"},"reference-count":71,"publisher":"IMR Press","issue":"11","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Despite ischemic heart disease (IHD) has been commonly identified as the consequence of obstructive coronary artery disease (OCAD), a significant percentage of patients undergoing coronary angiography because of signs and\/or symptoms of myocardial ischemia do not have any significant coronary artery stenosis. Several mechanisms other than coronary atherosclerosis, including coronary microvascular dysfunction (CMD), coronary endothelial dysfunction and epicardial coronary vasospasm, can determine myocardial ischemia or even myocardial infarction in the absence of flow-limiting epicardial coronary stenosis, highlighting the need of performing adjunctive diagnostic tests at the time of coronary angiography to achieve a correct diagnosis. This review provides updated evidence of the pathophysiologic mechanisms of myocardial ischemia with non-obstructive coronary arteries, focusing on the diagnostic and therapeutic implications of performing a comprehensive invasive functional evaluation consisting of the assessment of both vasodilation and vasoconstriction disorders. Moreover, performing a comprehensive invasive functional assessment may have important prognostic and therapeutic implications both in patients presenting with myocardial ischemia with non-obstructive coronary arteries (INOCA) or myocardial infarction with non-obstructive coronary arteries (MINOCA), as the implementation of a tailored patient management demonstrated to improve patient\u2019s symptoms and prognosis. However, given the limited knowledge of myocardial ischaemia with non-obstructive coronary arteries, there are no specific therapeutic interventions for these patients, and further research is warranted aiming to elucidate the underlying mechanisms and risk factors and to develop personalized forms of treatment.<\/jats:p>","DOI":"10.31083\/j.rcm2311371","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T05:23:46Z","timestamp":1667193826000},"source":"Crossref","is-referenced-by-count":14,"title":["Invasive Functional Coronary Assessment in Myocardial Ischemia with Non-Obstructive Coronary Arteries: from Pathophysiological Mechanisms to Clinical Implications"],"prefix":"10.31083","volume":"23","author":[{"given":"Riccardo","family":"Rinaldi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Salzillo","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Caff\u00e8","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco A.","family":"Montone","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update from the GBD 2019 Study. Journal of the American College of Cardiology. 2020; 76: 2982\u20133021.","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018; 39: 119\u2013177.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020; 41: 407\u2013477.","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Collet JP, Thiele H, Barbato E, Barth\u00e9l\u00e9my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2021; 42: 1289\u20131367.","DOI":"10.1093\/eurheartj\/ehaa909"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kaski JC, Crea F, Gersh BJ, Camici PG. Reappraisal of Ischemic Heart Disease. Circulation. 2018; 138: 1463\u20131480.","DOI":"10.1161\/CIRCULATIONAHA.118.031373"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women\u2019s Ischemia Syndrome Evaluation) study. Journal of the American College of Cardiology. 2010; 55: 2825\u20132832.","DOI":"10.1016\/j.jacc.2010.01.054"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000; 101: 948\u2013954.","DOI":"10.1161\/01.CIR.101.9.948"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Planer D, Mehran R, Ohman EM, White HD, Newman JD, Xu K, et al. Prognosis of Patients with Non\u2013ST-Segment\u2013Elevation Myocardial Infarction and Nonobstructive Coronary Artery Disease. Circulation: Cardiovascular Interventions. 2014; 7: 285\u2013293.","DOI":"10.1161\/CIRCINTERVENTIONS.113.000606"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Montone RA, Niccoli G, Fracassi F, Russo M, Gurgoglione F, Camm\u00e0 G, et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. European Heart Journal. 2018; 39: 91\u201398.","DOI":"10.1093\/eurheartj\/ehx667"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Montone RA, Niccoli G, Russo M, Giaccari M, Del Buono MG, Meucci MC, et al. Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries. Clinical Research in Cardiology. 2020; 109: 435\u2013443.","DOI":"10.1007\/s00392-019-01523-w"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Niccoli G, Montone RA, Lanza GA, Crea F. Angina after percutaneous coronary intervention: the need for precision medicine. International Journal of Cardiology. 2017; 248: 14\u201319.","DOI":"10.1016\/j.ijcard.2017.07.105"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. The American Journal of Cardiology. 1974; 33: 87\u201394.","DOI":"10.1016\/0002-9149(74)90743-7"},{"key":"ref13","unstructured":"Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, et al. International standardization of diagnostic criteria for vasospastic angina. European Heart Journal. 2017; 38: 2565\u20132568."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Camilli M, Russo M, Rinaldi R, Caff\u00e8 A, La Vecchia G, Bonanni A, et al. Air Pollution and Coronary Vasomotor Disorders in Patients With Myocardial Ischemia and Unobstructed Coronary Arteries. Journal of the American College of Cardiology. 2022; 80: 1818\u20131828.","DOI":"10.1016\/j.jacc.2022.08.744"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Beltrame JF, Crea F, Camici P. Advances in coronary microvascular dysfunction. Heart, Lung and Circulation. 2009; 18: 19\u201327.","DOI":"10.1016\/j.hlc.2008.11.002"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Padro T, Manfrini O, Bugiardini R, Canty J, Cenko E, De Luca G, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on \u2018coronary microvascular dysfunction in cardiovascular disease\u2019. Cardiovascular Research. 2020; 116: 741\u2013755.","DOI":"10.1093\/cvr\/cvaa003"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Taqueti VR, Di Carli MF. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options. Journal of the American College of Cardiology. 2018; 72: 2625\u20132641.","DOI":"10.1016\/j.jacc.2018.09.042"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Camici PG, Crea F. Coronary Microvascular Dysfunction. New England Journal of Medicine. 2007; 356: 830\u2013840.","DOI":"10.1056\/NEJMra061889"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Crea F, Montone RA, Rinaldi R. Pathophysiology of Coronary Microvascular Dysfunction. Circulation Journal. 2022; 86: 1319\u20131328.","DOI":"10.1253\/circj.CJ-21-0848"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. European Heart Journal. 2014; 35: 1101\u20131111.","DOI":"10.1093\/eurheartj\/eht513"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Del Buono MG, Montone RA, Camilli M, Carbone S, Narula J, Lavie CJ, et al. Coronary Microvascular Dysfunction across the Spectrum of Cardiovascular Diseases. Journal of the American College of Cardiology. 2021; 78: 1352\u20131371.","DOI":"10.1016\/j.jacc.2021.07.042"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Montone RA, Iannaccone G, Meucci MC, Gurgoglione F, Niccoli G. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019. European Cardiology. 2020; 15: e52.","DOI":"10.15420\/ecr.2020.22"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019; 40: 87\u2013165.","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Montone RA, Galiuto L, Meucci MC, Del Buono MG, Vergni F, Camilli M, et al. Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome. Heart. 2020; 106: 923\u2013930.","DOI":"10.1136\/heartjnl-2019-315909"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ong P, Camici PG, Beltrame JF, Crea F, Shimokawa H, Sechtem U, et al. International standardization of diagnostic criteria for microvascular angina. International Journal of Cardiology. 2018; 250: 16\u201320.","DOI":"10.1016\/j.ijcard.2017.08.068"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ong P, Safdar B, Seitz A, Hubert A, Beltrame JF, Prescott E. Diagnosis of coronary microvascular dysfunction in the clinic. Cardiovascular Research. 2020; 116: 841\u2013855.","DOI":"10.1093\/cvr\/cvz339"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Perera D, Berry C, Hoole SP, Sinha A, Rahman H, Morris PD, et al. Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation\/National Institute for Health Research Partnership. Heart. 2022: heartjnl\u20132021\u201320718.","DOI":"10.1136\/heartjnl-2021-320718"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Rahman H, Demir OM, Ryan M, McConkey H, Scannell C, Ellis H, et al. Optimal Use of Vasodilators for Diagnosis of Microvascular Angina in the Cardiac Catheterization Laboratory. Circulation: Cardiovascular Interventions. 2020; 13: e009019.","DOI":"10.1161\/CIRCINTERVENTIONS.120.009019"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"AlBadri A, Bairey Merz CN, Johnson BD, Wei J, Mehta PK, Cook-Wiens G, et al. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women. Journal of the American College of Cardiology. 2019; 73: 684\u2013693.","DOI":"10.1016\/j.jacc.2018.11.040"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Lee JM, Jung J, Hwang D, Park J, Fan Y, Na S, et al. Coronary Flow Reserve and Microcirculatory Resistance in Patients with Intermediate Coronary Stenosis. Journal of the American College of Cardiology. 2016; 67: 1158\u20131169.","DOI":"10.1016\/j.jacc.2015.12.053"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Kelshiker MA, Seligman H, Howard JP, Rahman H, Foley M, Nowbar AN, et al. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. European Heart Journal. 2022; 43: 1582\u20131593.","DOI":"10.1093\/eurheartj\/ehab775"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Xaplanteris P, Fournier S, Keulards DCJ, Adjedj J, Ciccarelli G, Milkas A, et al. Catheter-Based Measurements of Absolute Coronary Blood Flow and Microvascular Resistance. Circulation: Cardiovascular Interventions. 2018; 11: e006194.","DOI":"10.1161\/CIRCINTERVENTIONS.117.006194"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Fearon WF, Balsam LB, Farouque HMO, Robbins RC, Fitzgerald PJ, Yock PG, et al. Novel Index for Invasively Assessing the Coronary Microcirculation. Circulation. 2003; 107: 3129\u20133132.","DOI":"10.1161\/01.CIR.0000080700.98607.D1"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006; 113: 2054\u20132061.","DOI":"10.1161\/CIRCULATIONAHA.105.603522"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Williams RP, de Waard GA, De Silva K, Lumley M, Asrress K, Arri S, et al. Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients with Acute Myocardial Infarction or Stable Angina Pectoris. The American Journal of Cardiology. 2018; 121: 1\u20138.","DOI":"10.1016\/j.amjcard.2017.09.012"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas AHEM, et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. European Heart Journal. 2020; 41: 3504\u20133520.","DOI":"10.1093\/eurheartj\/ehaa503"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Montone RA, Meucci MC, De Vita A, Lanza GA, Niccoli G. Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications. Atherosclerosis. 2021; 318: 14\u201321.","DOI":"10.1016\/j.atherosclerosis.2020.12.008"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Zaya M, Mehta PK, Bairey Merz CN. Provocative Testing for Coronary Reactivity and Spasm. Journal of the American College of Cardiology. 2014; 63: 103\u2013109.","DOI":"10.1016\/j.jacc.2013.10.038"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Montone RA, Rinaldi R, Del Buono MG, Gurgoglione F, La Vecchia G, Russo M, et al. Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries. EuroIntervention. 2022: 18: e666\u2013e676.","DOI":"10.4244\/EIJ-D-21-00971"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation. 1987; 75: 577\u2013582.","DOI":"10.1161\/01.CIR.75.3.577"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina. Journal of the American College of Cardiology. 2018; 72: 2841\u20132855.","DOI":"10.1016\/j.jacc.2018.09.006"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Kosugi M, Nakagomi A, Shibui T, Kato K, Kusama Y, Atarashi H, et al. Effect of Long-Term Nitrate Treatment on Cardiac Events in Patients with Vasospastic Angina. Circulation Journal. 2011; 75: 2196\u20132205.","DOI":"10.1253\/circj.CJ-11-0056"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Russo G, Di Franco A, Lamendola P, Tarzia P, Nerla R, Stazi A, et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovascular Drugs and Therapy. 2013; 27: 229\u2013234.","DOI":"10.1007\/s10557-013-6439-z"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Neglia D, Fommei E, Varela-Carver A, Mancini M, Ghione S, Lombardi M, et al. Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. Journal of Hypertension. 2011; 29: 364\u2013372.","DOI":"10.1097\/HJH.0b013e328340a08e"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women\u2019s Ischemia Syndrome Evaluation (WISE). American Heart Journal. 2011; 162: 678\u2013684.","DOI":"10.1016\/j.ahj.2011.07.011"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation. 1982; 65: 281\u2013285.","DOI":"10.1161\/01.CIR.65.2.281"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Ishii M, Kaikita K, Sato K, Yamanaga K, Miyazaki T, Akasaka T, et al. Impact of Statin Therapy on Clinical Outcome in Patients with Coronary Spasm. Journal of the American Heart Association. 2016; 5: e003426.","DOI":"10.1161\/JAHA.116.003426"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Jaw-Wen C, Wen-Lieng L, Nai-Wei H, Shing-Jong L, Chih-Tai T, Shih-Pu W, et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. The American Journal of Cardiology. 1997; 80: 32\u201338.","DOI":"10.1016\/S0002-9149(97)00279-8"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Bairey Merz CN, Handberg EM, Shufelt CL, Mehta PK, Minissian MB, Wei J, et al. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. European Heart Journal. 2016; 37: 1504\u20131513.","DOI":"10.1093\/eurheartj\/ehv647"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Villano A, Di Franco A, Nerla R, Sestito A, Tarzia P, Lamendola P, et al. Effects of Ivabradine and Ranolazine in Patients with Microvascular Angina Pectoris. The American Journal of Cardiology. 2013; 112: 8\u201313.","DOI":"10.1016\/j.amjcard.2013.02.045"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients with Vasospastic Angina. Circulation. 2002; 105: 1545\u20131547.","DOI":"10.1161\/hc1002.105938"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. Journal of the American College of Cardiology. 2003; 41: 15\u201319.","DOI":"10.1016\/S0735-1097(02)02632-3"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Suda A, Takahashi J, Hao K, Kikuchi Y, Shindo T, Ikeda S, et al. Coronary Functional Abnormalities in Patients with Angina and Nonobstructive Coronary Artery Disease. Journal of the American College of Cardiology. 2019; 74: 2350\u20132360.","DOI":"10.1016\/j.jacc.2019.08.1056"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Sorop O, van den Heuvel M, van Ditzhuijzen NS, de Beer VJ, Heinonen I, van Duin RWB, et al. Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia. American Journal of Physiology-Heart and Circulatory Physiology. 2016; 311: H1339\u2013H1351.","DOI":"10.1152\/ajpheart.00458.2015"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Handberg EM, Merz CNB, Cooper-Dehoff RM, Wei J, Conlon M, Lo MC, et al. Rationale and design of the Women\u2019s Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial. American Heart Journal. 2021; 237: 90\u2013103.","DOI":"10.1016\/j.ahj.2021.03.011"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Jespersen L, Hvelplund A, Abildstrom SZ, Pedersen F, Galatius S, Madsen JK, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. European Heart Journal. 2012; 33: 734\u2013744.","DOI":"10.1093\/eurheartj\/ehr331"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Rahman H, Demir OM, Khan F, Ryan M, Ellis H, Mills MT, et al. Physiological Stratification of Patients with Angina Due to Coronary Microvascular Dysfunction. Journal of the American College of Cardiology. 2020; 75: 2538\u20132549.","DOI":"10.1016\/j.jacc.2020.03.051"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O\u2019Brien SM, Boden WE, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. The New England Journal of Medicine. 2020; 382: 1395\u20131407.","DOI":"10.1056\/NEJMoa1915922"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Niccoli G, Scalone G, Crea F. Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. European Heart Journal. 2015; 36: 475\u2013481.","DOI":"10.1093\/eurheartj\/ehu469"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Montone RA, Jang I, Beltrame JF, Sicari R, Meucci MC, Bode M, et al. The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries. Progress in Cardiovascular Diseases. 2021; 68: 78\u201387.","DOI":"10.1016\/j.pcad.2021.08.004"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Montone RA, Niccoli G, Crea F, Jang I. Management of non-culprit coronary plaques in patients with acute coronary syndrome. European Heart Journal. 2020; 41: 3579\u20133586.","DOI":"10.1093\/eurheartj\/ehaa481"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Crea F, Niccoli G. Myocardial Infarction with Nonobstructive Coronary Atherosclerosis. JACC: Cardiovascular Imaging. 2019; 12: 2222\u20132224.","DOI":"10.1016\/j.jcmg.2018.09.003"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Nordenskj\u00f6ld AM, Agewall S, Atar D, Baron T, Beltrame J, Bergstr\u00f6m O, et al. Randomized evaluation of beta blocker and ACE-inhibitor\/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design. American Heart Journal. 2021; 231: 96\u2013104.","DOI":"10.1016\/j.ahj.2020.10.059"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Lindahl B, Baron T, Erlinge D, Hadziosmanovic N, Nordenskj\u00f6ld A, Gard A, et al. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients with Myocardial Infarction with Nonobstructive Coronary Artery Disease. Circulation. 2017; 135: 1481\u20131489.","DOI":"10.1161\/CIRCULATIONAHA.116.026336"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015; 131: 861\u2013870.","DOI":"10.1161\/CIRCULATIONAHA.114.011201"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Del Buono MG, Montone RA, Iannaccone G, Meucci MC, Rinaldi R, D\u2019Amario D, et al. Diagnostic work-up and therapeutic implications in MINOCA: need for a personalized approach. Future Cardiology. 2021; 17: 149\u2013154.","DOI":"10.2217\/fca-2020-0052"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Del Buono MG, La Vecchia G, Rinaldi R, Sanna T, Crea F, Montone RA. Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine. Current Opinion in Cardiology. 2022; 37: 481\u2013487.","DOI":"10.1097\/HCO.0000000000000998"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Montone RA, Cosentino N, Graziani F, Gorla R, Del Buono MG, La Vecchia G, et al. Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial. EuroIntervention. 2022: EIJ\u2013D\u201322\u201300178.","DOI":"10.4244\/EIJ-D-22-00178"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Sternheim D, Power DA, Samtani R, Kini A, Fuster V, Sharma S. Myocardial Bridging: Diagnosis, Functional Assessment, and Management. Journal of the American College of Cardiology. 2021; 78: 2196\u20132212.","DOI":"10.1016\/j.jacc.2021.09.859"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Matta A, Nader V, Canitrot R, Delmas C, Bouisset F, Lhermusier T, et al. Myocardial bridging is significantly associated to myocardial infarction with non-obstructive coronary arteries. European Heart Journal. Acute Cardiovascular Care. 2022; 11: 501\u2013507.","DOI":"10.1093\/ehjacc\/zuac047"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Montone RA, Gurgoglione FL, Del Buono MG, Rinaldi R, Meucci MC, Iannaccone G, et al. Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non-Obstructive Coronary Arteries: Pathogenic and Prognostic Implications. Journal of the American Heart Association. 2021;10: e020535.","DOI":"10.1093\/ehjacc\/zuab020.139"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/11\/10.31083\/j.rcm2311371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:28:48Z","timestamp":1732714128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/11\/10.31083\/j.rcm2311371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"alternative-id":["S1530-6550(22)00729-3"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2311371","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"371"}}